Kolon Life Science Inc. (102940)
Market Closed
11 Aug, 06:30
KRX SM KRX SM Primary ₩
16,090. 00
-290
-1.7705%
₩
655.95B Market Cap
- P/E Ratio
- Div Yield
25,187 Volume
- Eps
₩ 16,380
Previous Close Want to track 102940 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kolon Life Science Inc. (102940) Statistics
Valuation metrics
Market Cap 655.95B
Enterprise value 305.99B
Trailing P/E (ttm) 5.58
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 0.96
Price/Book (mrq) 0.26
Enterprise Value/Revenue 1.43
Enterprise Value/EBITDA 6.4
Overview
Shares outstanding 11.41M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 365.2K
Average volume (90 days) 122.49K
Price summary
52-Week low 13,210
52-Week high 72,700
Beta -
50-Day moving average 31,363.14
200-Day moving average 50,632.67
Dividends and splits
Forward annual dividend rate 533.33
Forward annual dividend yield 0.0098%
Trailing annual dividend rate 133.33
Trailing annual dividend yield 0.0025%
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:1
Last split Date 27 Dec 2017
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.17%
Operating margin 0.18%
Operational effectiveness
Return on assets 0.03%
Return on equity 0.07%
Income Statement
Revenue (ttm) 208.98B
Revenue per share (ttm) 16,408.78
Quarterly revenue growth (yoy) 0.11%
Gross profit (ttm) 55.89B
EBITDA 15.08B
Net income to common (ttm) 24.96B
Diluted EPS (ttm) 2,711.23
Quarterly earnings growth (yoy) 0.11%
Balance Sheet
Total cash (mrq) 10.64B
Total cash per share (mrq) 737.42
Total debt (mrq) 103.73B
Total Debt/Equity (mrq) 0.14
Current ratio (mrq) 0.73%
Book value per share (mrq) 60,178.9
Cash Flow
Cash flow statement 1.24B
Levered free cash flow (LFCF) 24.96B
